Mitoxantrone April 12, 2017 Mitoxantrone Trade Name Novantrone Orphan Indication Secondary-progressive multiple sclerosis USA Market Approval USA USA Designation Date 1999-08-13 00:00:00 Sponsor Serono, Inc.;One Technoloogy Place;Rockland, Massachusetts, 02370
